Technical Analysis for NAVB - Navidea Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.129 -5.84% -0.01
NAVB closed down 5.84 percent on Monday, March 18, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NAVB trend table...

Date Alert Name Type % Chg
Mar 18 Lower Bollinger Band Walk Weakness 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Lower Bollinger Band Touch Weakness 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 Hammer Candlestick Bullish -5.84%
Mar 15 Lower Bollinger Band Walk Weakness -5.84%
Mar 15 Outside Day Range Expansion -5.84%
Mar 15 Wide Bands Range Expansion -5.84%
Mar 15 Lower Bollinger Band Touch Weakness -5.84%
Mar 15 Oversold Stochastic Weakness -5.84%

Older signals for NAVB ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. The company's radiopharmaceutical development programs include Lymphoseek Injection, a receptor-targeted small-molecule investigational radiopharmaceutical that is used in lymphatic mapping procedures, which are performed to help stage breast cancer and melanoma; and NAV4694, an F-18 radiolabeled positron emission tomography imaging agent, which is used as an aid in the diagnosis of patients with signs or symptoms of cognitive impairment, such as Alzheimer's disease. Its radiopharmaceutical development programs also comprise NAV5001, an Iodine-123 radiolabeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinson's disease and other movement disorders with potential use as a diagnostic aid in dementia; and RIGScan, a radiolabeled monoclonal antibody that is developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, primarily colorectal cancer. It has research and development agreements with University of California, AstraZeneca AB, Alseres Pharmaceuticals, Inc., and The Ohio State University. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.
Medicine Biopharmaceutical Surgery Alzheimer's Disease Parkinson's Disease Medical Physics Melanoma Dementia Tomography Movement Disorders Medicinal Radiochemistry Radiopharmaceuticals Metastasis Nuclear Medicine University Of California Cognitive Impairment F 18 Positron Emission Tomography Radiochemistry
Is NAVB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.41
52 Week Low 0.1
Average Volume 443,057
200-Day Moving Average 0.1885
50-Day Moving Average 0.1501
20-Day Moving Average 0.1578
10-Day Moving Average 0.147
Average True Range 0.0179
ADX 18.43
+DI 10.9649
-DI 16.2281
Chandelier Exit (Long, 3 ATRs ) 0.1363
Chandelier Exit (Short, 3 ATRs ) 0.1778
Upper Bollinger Band 0.1889
Lower Bollinger Band 0.1267
Percent B (%b) 0.04
BandWidth 39.416984
MACD Line -0.0061
MACD Signal Line -0.0012
MACD Histogram -0.0049
Fundamentals Value
Market Cap 20.9 Million
Num Shares 162 Million
EPS 0.48
Price-to-Earnings (P/E) Ratio 0.27
Price-to-Sales 3.31
Price-to-Book 4.17
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.15
Resistance 3 (R3) 0.15 0.15 0.15
Resistance 2 (R2) 0.15 0.14 0.15 0.15
Resistance 1 (R1) 0.14 0.14 0.13 0.14 0.15
Pivot Point 0.13 0.13 0.13 0.13 0.13
Support 1 (S1) 0.12 0.12 0.12 0.12 0.11
Support 2 (S2) 0.12 0.12 0.11 0.11
Support 3 (S3) 0.11 0.12 0.11
Support 4 (S4) 0.11